Literature DB >> 7647972

Differences in response to 5-HT4 receptor agonists and antagonists of the 5-HT4-like receptor in human colon circular smooth muscle.

F S Tam1, K Hillier, K T Bunce, C Grossman.   

Abstract

1. In isolated circular smooth muscle strips of human colon 5-hydroxytryptamine (5-HT) produced a concentration-related inhibition of spontaneous motility. 2. The azabicycloalkyl benzimidazolones, BIMU 8 and BIMU 1, which have 5-HT4 receptor stimulant properties, inhibited motility with EC50 values of 0.76 microM and 3.19 microM respectively and their Emax values were not significantly different from 5-HT (EC50, 0.13 microM). 3. The 5-HT4 receptor antagonist, DAU 6285 (1-10 microM), displaced the 5-HT concentration-response curve to the right in a parallel concentration-dependent manner without depressing the maximum. The Schild plot was linear and the slope did not differ significantly from unity giving a pA2 value of 6.32. 4. The high affinity selective 5-HT4 receptor antagonist, GR 113808, at a concentration of 3 nM displaced the 5-HT concentration-response curve in a parallel manner giving an apparent pKB estimate of 8.9 +/- 0.24. However, higher concentrations of 10-100 nM GR 113808 did not result in a further significant displacement of the 5-HT concentration-response curve and there was no suppression of Emax. 5. GR 113808 (10 nM) also caused a parallel displacement of the concentration-response curve to the 5-HT4 receptor agonist, 5-methoxytryptamine (5-MeOT) giving apparent pKB values ranging from 8.3-9.3. 6. GR 113808 (3-100 nM) failed to displace 5-HT or 5-MeOT concentration-response curves in tissue strips from 3 patients out of a total of 10 patients studied in whom the response to 5-HT and 5-MeOT was normal. 7. The 5-HT4 receptor antagonist, SDZ 205-557 (0.3-10 microM), had no significant effect on 5-HT-induced inhibition of spontaneous motility.8. The present results are discussed in the light of variability of response to GR 113808 and SDZ205-557 in other tissues.9. Overall, our data indicate that human colon circular smooth muscle can be regarded as a site in which 5-HT4-like receptors are present but it is as yet unclear whether these results are also an indication of receptor variation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7647972      PMCID: PMC1908740          DOI: 10.1111/j.1476-5381.1995.tb16335.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  25 in total

1.  5-HT4 receptors, present in piglet atria and sensitive to SDZ 205-557, are absent in papillary muscle.

Authors:  J Lorrain; A Grosset; S E O'Connor
Journal:  Eur J Pharmacol       Date:  1992-12-08       Impact factor: 4.432

2.  The action of SDZ 205,557 at 5-hydroxytryptamine (5-HT3 and 5-HT4) receptors.

Authors:  R M Eglen; R Alvarez; L G Johnson; E Leung; E H Wong
Journal:  Br J Pharmacol       Date:  1993-02       Impact factor: 8.739

3.  Evidence for the involvement of a 5-HT4 receptor in the secretory response of human small intestine to 5-HT.

Authors:  R A Borman; D E Burleigh
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

4.  Benzimidazolone derivatives act as 5-HT4 receptor ligands in rat oesophagus.

Authors:  G S Baxter; D E Clarke
Journal:  Eur J Pharmacol       Date:  1992-03-03       Impact factor: 4.432

5.  Blockade of human atrial 5-HT4 receptors by GR 113808.

Authors:  A J Kaumann
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

6.  Characterization of the 5-HT4 receptor mediating tachycardia in piglet isolated right atrium.

Authors:  A D Medhurst; A J Kaumann
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

7.  Development of a radioligand binding assay for 5-HT4 receptors in guinea-pig and rat brain.

Authors:  C J Grossman; G J Kilpatrick; K T Bunce
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

8.  Pharmacological analyses of endo-6-methoxy-8-methyl-8-azabicyclo[3.2.1]oct-3-yl-2,3-dihydro-2-oxo-1 H- benzimidazole-1-carboxylate hydrochloride (DAU 6285) at the 5-hydroxytryptamine4 receptor in the tunica muscularis mucosae of rat esophagus and ileum of guinea pig: role of endogenous 5-hydroxytryptamine.

Authors:  M V Waikar; S S Hegde; A P Ford; D E Clarke
Journal:  J Pharmacol Exp Ther       Date:  1993-02       Impact factor: 4.030

9.  Characterization of a novel 5-HT4 receptor antagonist of the azabicycloalkyl benzimidazolone class: DAU 6285.

Authors:  A Dumuis; H Gozlan; M Sebben; H Ansanay; C A Rizzi; M Turconi; E Monferini; E Giraldo; P Schiantarelli; H Ladinsky
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-03       Impact factor: 3.000

10.  Comparison of the positive inotropic effects of serotonin, histamine, angiotensin II, endothelin and isoprenaline in the isolated human right atrium.

Authors:  H R Zerkowski; A Broede; K Kunde; S Hillemann; E Schäfer; M Vogelsang; M C Michel; O E Brodde
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-04       Impact factor: 3.000

View more
  11 in total

1.  Pharmacological characterization of 5-HT4 receptors mediating relaxation of canine isolated rectum circular smooth muscle.

Authors:  N H Prins; J F Van Haselen; R A Lefebvre; M R Briejer; L M Akkermans; J A Schuurkes
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

2.  An improved in vitro bioassay for the study of 5-HT(4) receptors in the human isolated large intestinal circular muscle.

Authors:  N H Prins; N P Shankley; N J Welsh; M R Briejer; R A Lefebvre; L M Akkermans; J A Schuurkes
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

Review 3.  Pharmacology of serotonin: what a clinician should know.

Authors:  F De Ponti
Journal:  Gut       Date:  2004-10       Impact factor: 23.059

4.  Evidence for 5-HT7 receptors mediating relaxation of human colonic circular smooth muscle.

Authors:  N H Prins; M R Briejer; P J Van Bergen; L M Akkermans; J A Schuurkes
Journal:  Br J Pharmacol       Date:  1999-10       Impact factor: 8.739

Review 5.  Irritable bowel syndrome: new agents targeting serotonin receptor subtypes.

Authors:  F De Ponti; M Tonini
Journal:  Drugs       Date:  2001       Impact factor: 9.546

6.  Presynaptic modulation of cholinergic neurotransmission in the human proximal stomach.

Authors:  Pascal G Leclere; Romain A Lefebvre
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

7.  Effects of 5-HT2B, 5-HT3 and 5-HT4 receptor antagonists on gastrointestinal motor activity in dogs.

Authors:  Hiroki Morita; Erito Mochiki; Nobuyuki Takahashi; Kiyoshi Kawamura; Akira Watanabe; Toshinaga Sutou; Atsushi Ogawa; Mitsuhiro Yanai; Kyoichi Ogata; Takaaki Fujii; Tetsuro Ohno; Souichi Tsutsumi; Takayuki Asao; Hiroyuki Kuwano
Journal:  World J Gastroenterol       Date:  2013-10-21       Impact factor: 5.742

8.  A comparison of the pharmacological properties of guinea-pig and human recombinant 5-HT4 receptors.

Authors:  R G Vickery; N Mai; E Kaufman; D T Beattie; T Pulido-Rios; M O'Keefe; P P A Humphrey; J A M Smith
Journal:  Br J Pharmacol       Date:  2007-02-12       Impact factor: 8.739

9.  Comparison of 5-HT4 receptors in guinea-pig colon and rat oesophagus: effects of novel agonists and antagonists.

Authors:  E Leung; M T Pulido-Rios; D W Bonhaus; L A Pekins; K D Zeitung; S A Hsu; R D Clark; E H Wong; R M Eglen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-07       Impact factor: 3.000

10.  Further investigation into the signal transduction mechanism of the 5-HT4-like receptor in the circular smooth muscle of human colon.

Authors:  P G McLean; I M Coupar
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.